Press Releases
 
Select:
Nov 12, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2020 Ended September 30, 2019 and Provides Conference Call Information
Nov 06, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2020 Financial Results on November 13, 2019
Sep 12, 2019
Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo
Aug 11, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2020 Ended June 30, 2019 and Provides Conference Call Information
Aug 07, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2020 Financial Results on August 12, 2019
Jun 28, 2019
Elite Pharmaceuticals Announces Commercial Launch of Dantrolene Capsules with Marketing Partner Lannett Company
Jun 21, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2019 and Provides Conference Call Information
Jun 14, 2019
Elite Pharmaceuticals, Inc. Delays Fourth Quarter and Year End 2019 Earnings Release Date and Conference Call
Jun 11, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-end Financial Results on June 17, 2019
Mar 11, 2019
Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®
 1   2     3    4   5   6   7   8 
 <<   <   >   >>